Mode
Text Size
Log in / Sign up

24-week self-determined sequence exercise program shows significant interactions for sarcopenia reversal in older adultsNew study tests exercise mix for muscle loss in older adults

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider the self-determined sequence exercise program for sarcopenia, noting significant interactions but missing effect sizes and safety data.

This randomized controlled trial evaluated a self-determined sequence exercise program in 91 older adults with sarcopenia between 60 and 75 years of age. The intervention included resistance exercises, Taichi, and a hybrid program over 24 weeks, compared with resistance training alone and a control group. The study setting and funding sources were not reported.

Secondary outcomes assessed included L3 skeletal muscle density, L3 skeletal muscle area, muscle fat infiltration, handgrip strength, and relative skeletal muscle mass index. Statistically significant Group × Time interactions were detected for these measures, though specific absolute numbers and confidence intervals were not provided. Additionally, a stacking model demonstrated 84.5% accuracy and an F1-score of 68.8% for predicting sarcopenia reversal. Within the self-determined sequence group, strength training was noted to contribute most to reversal, although comparative effect sizes were not reported.

Safety and tolerability data, including adverse events, discontinuations, and serious adverse events, were not reported. The study design suggests causal inference is intended, but the lack of detailed statistical reporting and safety information limits the precision of clinical conclusions. Generalizability remains uncertain given the single-arm nature of the specific intervention analysis and the small sample size.

Researchers conducted a randomized controlled trial to see if a flexible exercise program could help older adults with sarcopenia regain muscle function. The study involved 91 patients between the ages of 60 and 75 who were assigned to either a self-determined sequence group, a resistance training group, or a control group. Participants followed their assigned exercise plans for 24 weeks.

The analysis showed statistically significant interactions over time for several muscle measurements, including L3 skeletal muscle area and handgrip strength. Additionally, a predictive model used in the study achieved 84.5% accuracy in forecasting sarcopenia reversal. Within the flexible exercise group, strength training was identified as the component that contributed most to these positive changes.

No adverse events or safety issues were reported during the study period. Despite these positive signals, readers should be cautious because the report does not provide specific numbers on how much muscle mass increased or how much strength improved. The findings come from one study with a limited sample size, so they should not be viewed as definitive proof that this specific program works for everyone.

This research offers early hope for tailored exercise approaches but requires more data to confirm its benefits. Patients should discuss these options with their healthcare providers before making changes to their fitness routines.

What this means for you:
Small study shows mixed exercise may help muscle loss, but specific improvement numbers are missing.

Study Details

Study typeRct
Sample sizen = 31
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Resistance exercise, Taichi exercise, and the hybrid exercise program consisting of the two aforementioned methods have been demonstrated to increase the skeletal muscle mass of older individuals with sarcopenia. However, the exercise sequence has not been comprehensively investigated. Therefore, we designed a self-determined sequence exercise program, incorporating resistance exercises, Taichi, and the hybrid exercise program to overcome the decline of skeletal muscle area and reverse sarcopenia in older individuals. METHODS: Ninety-one older patients with sarcopenia between the ages of 60 and 75 completed this three-stage randomized controlled trial for 24 weeks, including the self-determined sequence exercise program group (n = 31), the resistance training group (n = 30), and the control group (n = 30). We used quantitative computed tomography to measure the effects of different intervention protocols on skeletal muscle mass in participants. Participants' demographic variables were analyzed using one-way analysis of variance and chi-square tests, and experimental data were examined using repeated-measures analysis of variance. Furthermore, we utilized the Markov model to explain the effectiveness of the exercise programs among the three-stage intervention and explainable artificial intelligence to predict whether intervention programs can reverse sarcopenia. RESULTS: Repeated-measures analysis of variance results indicated that there were statistically significant Group × Time interactions detected in the L3 skeletal muscle density, L3 skeletal muscle area, muscle fat infiltration, handgrip strength, and relative skeletal muscle mass index. The stacking model exhibited the best accuracy (84.5%) and the best F1-score (68.8%) compared to other algorithms. In the self-determined sequence exercise program group, strength training contributed most to the reversal of sarcopenia. CONCLUSION: One self-determined sequence exercise program can improve skeletal muscle area among sarcopenic older people. Based on our stacking model, we can predict whether sarcopenia in older people can be reversed accurately. The trial was registered in ClinicalTrials.gov. TRN:NCT05694117. SIGNIFICANCE: Our findings indicate that such tailored exercise interventions can substantially benefit sarcopenic patients, and our stacking model provides an accurate predictive tool for assessing the reversibility of sarcopenia in older adults. This approach not only enhances individual health outcomes but also informs future development of targeted exercise programs to mitigate age-related muscle decline.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.